| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |